Ftse Mib
34.249,77
0,91%
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
NASDAQ Composite
15.927,90
2,03%
Bitcoin
63.327,80
-0,65%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistenza
Home Investire Azioni U.S.A. NASDAQ AstraZeneca PLC (AZN) AstraZeneca PLC (AZN) Notizie

AstraZeneca PLC

AZN
75,17
0,14 (0,19%)
27 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
25/4/202414:00PRNUSAbelZeta Announces Abstract for C-CAR031 Accepted for..
25/4/202413:53IHMARKETNEWSU.S. Futures Drop in Pre-Market Trading as Tech Stocks..
25/4/202413:52IHMARKETNEWSSouthwest Shares Tumble 9.6% Post $231 Million 1Q Loss,..
25/4/202408:00BWQ1 2024 results
16/4/202413:00BWIMFINZI® (durvalumab) plus chemotherapy doubled overall..
12/4/202413:05IHMARKETNEWSParamount Global Board Shrinks, Morgan Stanley Faces..
11/4/202413:24IHMARKETNEWSCostco Increases Dividend by 14%, Meta Introduces ‘Artemis’..
11/4/202413:00BWFASENRA approved for treatment of children aged 6 to 11 with..
06/4/202405:10BWENHERTU® Approved in the U.S. as First Tumor Agnostic HER2..
06/4/202403:43BWENHERTU® (fam-trastuzumab deruxtecan-nxki) approved in the..
05/4/202413:00BWIMFINZI® (durvalumab) significantly improved overall..
02/4/202413:00BWDatopotamab deruxtecan Biologics License Application..
02/4/202408:00BWDatopotamab Deruxtecan Biologics License Application..
01/4/202413:00BWVOYDEYA™ approved in the US as add-on therapy to ravulizumab..
27/3/202411:54IHMARKETNEWSGameStop Shares Tumble 20% in Pre-Market Trading Amid..
26/3/202412:20IHMARKETNEWSSuper Micro Computer and Seagate Shares Surge on Analyst..
25/3/202412:00BWULTOMIRIS® (ravulizumab-cwvz) approved in the US for the..
19/3/202412:33IHMARKETNEWSUnilever Initiates Ice Cream Division Spin-Off and Announces..
19/3/202412:00BWAstraZeneca to acquire Fusion to accelerate the development..
19/3/202411:52IHMARKETNEWSAstraZeneca to acquire Fusion for $2 billion
18/3/202412:00BWAstraZeneca caps patient out-of-pocket costs at $35 per..
14/3/202412:39IHMARKETNEWSFisker’s Shares Take a Hit Amid Speculation of Bankruptcy,..
13/3/202412:06BWAstraZeneca announces initiation of THARROS – a Phase III..
07/3/202411:43IHMARKETNEWSTesla Exits Market Top 10, Victoria’s Secret Stock Tumbles..
26/2/202422:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/2/202415:00PRNCAAlexion Canada donne de la couleur aux maladies rares avec..
26/2/202412:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/2/202422:09EDGAR2Form 424B2 - Prospectus [Rule 424(b)(2)]
23/2/202419:23BWMANDARA Phase III data published in New England Journal of..
22/2/202415:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/2/202415:14EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/2/202413:10BWDatopotamab deruxtecan Biologics License Application..
19/2/202413:05BWTAGRISSO® (osimertinib) demonstrated overwhelming efficacy..
19/2/202408:00BWDatopotamab Deruxtecan Biologics License Application..
17/2/202404:00BWTAGRISSO® (osimertinib) with the addition of chemotherapy..
09/2/202411:51IHMARKETNEWSCloudflare Skyrockets 26% Pre-Market; Expedia Plunges 14%..
08/2/202412:10IHMARKETNEWSArm Achieves Record Revenue, PayPal Shares Plummet by More..
08/2/202408:03BWAstraZeneca Full year and Q4 2023 Financial Results
07/2/202413:31PRNUSSOPHiA GENETICS and AstraZeneca Spain Commit to Increasing..
07/2/202412:51PRNUSSOPHiA GENETICS and AstraZeneca Spain Commit to Increasing..
06/2/202415:00BWAstraZeneca expands US manufacturing footprint to accelerate..
05/2/202415:00GLOBEYiviva Announces Memorandum of Understanding with..
29/1/202413:00BWENHERTU® (fam-trastuzumab deruxtecan-nxki) granted Priority..
24/1/202423:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
22/1/202413:00BWAIRSUPRA® (albuterol/budesonide) now available as the first..
19/1/202416:05BWIMFINZI® (durvalumab) plus transarterial chemoembolization..
19/1/202414:46EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
19/1/202414:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/1/202412:15IHMARKETNEWSWall Street Highlights: Apple Cuts iPhone Prices in China,..
08/1/202414:45IHNWExciting New Cures Possible from GLP-1 Diabetes, Weight-Loss..
Apertura: 75,00 Min: 74,59 Max: 75,49
Chiusura: 75,03

La tua Cronologia

NASDAQ
AZN
AstraZeneca
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network